Literature DB >> 1370214

The NZB mouse as a model for chronic lymphocytic leukemia.

J A Phillips1, K Mehta, C Fernandez, E S Raveché.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and the only leukemia for which a possible genetic component has been described. Analysis of this genetic component has been hindered by the fact that disease onset normally occurs after age 50. We report here the aged NZB mouse as an animal model for CLL. NZB mice have a genetically regulated, age-dependent onset of clonal, aneuploid cells which are IgM+ and Ly1+ (CD5+ B-cells). Peripheral blood smears from old NZB mice show an increase in circulating lymphocytes and "smudged" or ruptured cells, often seen in human CLL. Electron microscopic examination of these cells shows them to be mature lymphocytes. Light microscopy of the spleen shows infiltration of small lymphocytes and is consistent with CLL pathology. These long-lived, CLL-like cells can be serially passaged into recipient animals. This continued passage occasionally results in the development of a large cell lymphoma detectable in the spleen, lymph nodes, and liver. The histology of this lymphoma is quite distinct from that of the CLL-like cells, but the phenotype is that of an aneuploid CD5+, IgM+ cells. This apparently represents a continued transformation of the CLL-like clone similar to the development of Richter's syndrome in human CLL. Therefore, the NZB mouse can be a valuable tool for the determination of the genetic basis of CLL ontogeny and the conversion of CLL into Richter's syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370214

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Light and electron microscope study of splenoportal milky spots in New Zealand black mice: comparison between splenoportal milky spots and aberrant spleens.

Authors:  N Takemori; K Hirai; R Onodera; N Saito; M Namiki
Journal:  J Anat       Date:  1995-04       Impact factor: 2.610

2.  Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

Authors:  S Ramachandra; R A Metcalf; T Fredrickson; G E Marti; E Raveche
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Light and electron microscopic study of omental milky spots in New Zealand black mice, with special reference to the extramedullary hematopoiesis.

Authors:  N Takemori; K Hirai; R Onodera; N Saito; M Namiki
Journal:  Anat Embryol (Berl)       Date:  1994-03

4.  The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.

Authors:  Erica Salerno; Yao Yuan; Brian J Scaglione; Gerald Marti; Alexander Jankovic; Fermina Mazzella; Maria Fernanda Laurindo; Daryl Despres; Sivasubramanian Baskar; Christoph Rader; Elizabeth Raveche
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

Review 5.  Aberrant responses of human lymphocytic neoplasms to cytokine regulation.

Authors:  P C Nowell; J S Moore
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.

Authors:  Roberta Bichi; Susan A Shinton; Eric S Martin; Anatoliy Koval; George A Calin; Rossano Cesari; Giandomenico Russo; Richard R Hardy; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.

Authors:  Shweta Jain; Jerrold M Ward; Dong-Mi Shin; Hongsheng Wang; Zohreh Naghashfar; Alexander L Kovalchuk; Herbert C Morse
Journal:  Am J Pathol       Date:  2017-07-17       Impact factor: 4.307

Review 8.  Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia.

Authors:  Audrey Mohr; Yves Renaudineau; Cristina Bagacean; Jacques-Olivier Pers; Christophe Jamin; Anne Bordron
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

9.  Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.

Authors:  Shibin Ma; Vipul Shukla; Leilei Fang; Karen A Gould; Shantaram S Joshi; Runqing Lu
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

Review 10.  Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.

Authors:  Brian J Scaglione; Erica Salerno; Murugabaskar Balan; Frederick Coffman; Pablo Landgraf; Fatima Abbasi; Sergei Kotenko; Gerald E Marti; Elizabeth S Raveche
Journal:  Br J Haematol       Date:  2007-10-17       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.